ARTEMISMED Stock Overview
Engages in the management and operation of multi specialty hospitals in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 6/6 |
Past Performance | 4/6 |
Financial Health | 2/6 |
Dividends | 2/6 |
Artemis Medicare Services Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹229.02 |
52 Week High | ₹249.00 |
52 Week Low | ₹118.55 |
Beta | 0.87 |
11 Month Change | 27.38% |
3 Month Change | 24.60% |
1 Year Change | 73.11% |
33 Year Change | 535.99% |
5 Year Change | n/a |
Change since IPO | 914.49% |
Recent News & Updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now
Jul 18Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce
Jul 16Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now
Jul 18Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce
Jul 16After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar
Apr 13Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Jun 14Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Mar 15Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal
Aug 31Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Jul 30Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return
May 13Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture
Jan 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Dec 10There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
Sep 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Jul 01There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
May 11We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt
Mar 16Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?
Jan 22Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Nov 13Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)
Jul 20Shareholder Returns
ARTEMISMED | IN Healthcare | IN Market | |
---|---|---|---|
7D | 21.8% | 0.5% | 1.2% |
1Y | 73.1% | 34.8% | 44.7% |
Return vs Industry: ARTEMISMED exceeded the Indian Healthcare industry which returned 35.6% over the past year.
Return vs Market: ARTEMISMED exceeded the Indian Market which returned 45.4% over the past year.
Price Volatility
ARTEMISMED volatility | |
---|---|
ARTEMISMED Average Weekly Movement | 6.9% |
Healthcare Industry Average Movement | 5.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in IN Market | 9.7% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: ARTEMISMED's share price has been volatile over the past 3 months.
Volatility Over Time: ARTEMISMED's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 1,991 | Devlina Chakravarty | www.artemishospitals.com |
Artemis Medicare Services Limited engages in the management and operation of multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a multi-specialty hospital located in Gurugram.
Artemis Medicare Services Limited Fundamentals Summary
ARTEMISMED fundamental statistics | |
---|---|
Market cap | ₹31.51b |
Earnings (TTM) | ₹491.41m |
Revenue (TTM) | ₹8.79b |
64.1x
P/E Ratio3.6x
P/S RatioIs ARTEMISMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARTEMISMED income statement (TTM) | |
---|---|
Revenue | ₹8.79b |
Cost of Revenue | ₹7.01b |
Gross Profit | ₹1.78b |
Other Expenses | ₹1.28b |
Earnings | ₹491.41m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.57 |
Gross Margin | 20.21% |
Net Profit Margin | 5.59% |
Debt/Equity Ratio | 55.8% |
How did ARTEMISMED perform over the long term?
See historical performance and comparison